These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 6335174)

  • 1. Changes in miniature end-plate potentials after brief nervous stimulation at the frog neuromuscular junction.
    Doherty P; Hawgood BJ; Smith IC
    J Physiol; 1984 Nov; 356():349-58. PubMed ID: 6335174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in miniature end-plate potentials due to moderate hypertonicity at the frog neuromuscular junction.
    Doherty P; Hawgood BJ; Smith IC
    J Physiol; 1986 Jul; 376():1-11. PubMed ID: 3491900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of botulinum toxin on neuromuscular transmission in the rat.
    Cull-Candy SG; Lundh H; Thesleff S
    J Physiol; 1976 Aug; 260(1):177-203. PubMed ID: 184273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synaptic depression in frog neuromuscular junction.
    Glavinović MI
    J Neurophysiol; 1987 Jul; 58(1):230-46. PubMed ID: 2441003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binomial analysis of quantal transmitter release at glycerol treated frog neuromuscular junctions.
    Miyamoto MD
    J Physiol; 1975 Aug; 250(1):121-42. PubMed ID: 240928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temperature-sensitive aspects of evoked and spontaneous transmitter release at the frog neuromuscular junction.
    Barrett EF; Barrett JN; Botz D; Chang DB; Mahaffey D
    J Physiol; 1978 Jun; 279():253-73. PubMed ID: 209175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The calcium dependence of spontaneous and evoked quantal release at the frog neuromuscular junction.
    Barton SB; Cohen IS; van der Kloot W
    J Physiol; 1983 Apr; 337():735-51. PubMed ID: 6603514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in MEPP frequency during depression of evoked release at the frog neuromuscular junction.
    Zengel JE; Sosa MA
    J Physiol; 1994 Jun; 477(Pt 2):267-77. PubMed ID: 7932218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of low temperature and terminal membrane potential on quantal size at frog neuromuscular junction.
    Cohen IS; Van der Kloot W
    J Physiol; 1983 Mar; 336():335-44. PubMed ID: 6308226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the role of barium in supporting the asynchronous release of acetylcholine quanta by motor nerve impulses.
    Silinsky EM
    J Physiol; 1978 Jan; 274():157-71. PubMed ID: 304889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lithium ions and the release of transmitter at the frog neuromuscular junction.
    Crawford AC
    J Physiol; 1975 Mar; 246(1):109-42. PubMed ID: 237119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease of quantal size and quantal content during tetanic stimulation detected by focal recording.
    Glavinović MI
    Neuroscience; 1995 Nov; 69(1):271-81. PubMed ID: 8637625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotransmitter release and nerve terminal morphology at the frog neuromuscular junction affected by the dye Erythrosin B.
    Augustine GJ; Levitan H
    J Physiol; 1983 Jan; 334():47-63. PubMed ID: 6134825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of an inhibitor of the synaptic vesicle acetylcholine transport system on quantal neurotransmitter release: an electrophysiological study.
    Lupa MT
    Brain Res; 1988 Sep; 461(1):118-26. PubMed ID: 3265645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyneuronal innervation and quantal transmitter release in formamide-treated frog sartorius muscles.
    Herrera AA
    J Physiol; 1984 Oct; 355():267-80. PubMed ID: 6149312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of tetanic and post-tetanic potentiation of miniature end-plate potentials at the frog neuromuscular junction.
    Lev-Tov A; Rahamimoff R
    J Physiol; 1980 Dec; 309():247-73. PubMed ID: 6973021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observations on the action of type A botulinum toxin on frog neuromuscular junctions.
    Boroff DA; del Castillo J; Evoy WH; Steinhardt RA
    J Physiol; 1974 Jul; 240(2):227-53. PubMed ID: 4371582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity increases quantal size at the frog neuromuscular junction.
    Van der Kloot W; Van der Kloot TE
    Experientia; 1985 Jan; 41(1):47-8. PubMed ID: 3871401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in miniature endplate potential frequency during repetitive nerve stimulation in the presence of Ca2+, Ba2+, and Sr2+ at the frog neuromuscular junction.
    Zengel JE; Magleby KL
    J Gen Physiol; 1981 May; 77(5):503-29. PubMed ID: 6262429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bimodal miniature and evoked end-plate potentials in adult mouse neuromuscular junctions.
    Kelly SS; Robbins N
    J Physiol; 1984 Jan; 346():353-63. PubMed ID: 6699778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.